Tafenoquine succinate
SIGMA/SML0396 - ≥95% (HPLC)
Synonym: N-
CAS Number: 106635-81-8
Empirical Formula (Hill Notation): C24H28F3N3O3 · C4H6O4
Molecular Weight: 581.58
MDL Number: MFCD00892249
Linear Formula: C24H28F3N3O3 · C4H6O4
Product Type: Chemical
assay | ≥95% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C24H28F3N3O3.C4H6O4/c1 |
InChI key | CQBKFGJRAOXYIP-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | OC(=O)CCC(O)=O.COc1cc(C)c |
solubility | DMSO: 5 mg/mL (clear solution) |
storage condition | desiccated |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Tafenoquine has been generally generated for oral administration and drug absorption increases when taken along with food. It is known to possess a longer half life. |
Biochem/physiol Actions: | Tafenoquine is an antimalarial primaquine analog being investigated to treat and prevent Plasmodium vivax infections. It can eliminate both blood and liver stages of Plasmodium vivax. Tafenoquine has also been tested as a therapy for leishmaniasis. |
Packaging: | 10, 50 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥95% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |